Skip to content
Company Analysis

JIN MEDICAL INTERNATIONAL LTD. ZJYL

A comprehensive view of key metrics, scores, and financial health for JIN MEDICAL INTERNATIONAL LTD.

Overview of Jin Medical International Ltd.

ZJYL NCM
Healthcare Medical Instruments & Supplies Micro Cap
Jin Medical International Ltd. (ZJYL), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $0.12, about 108.3% undervalued vs fair value, -86.7% 1Y return, ranked 577/1110 in sector.
$0.12
1.72%
As of March 13, 2026
Previous close • Vol 90d: 115.3%
52-Week Range
Market Cap
$22.78M
Enterprise Value
$34.23M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for JIN MEDICAL INTERNATIONAL LTD..

Top Beats

Quick Facts

Website https://www.zhjmedical.com
HQ Changzhou
Employees 273
Fiscal year Sep 30

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$0
$0
$0
Current: $0.12 +108% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$20.7M
-12%%
Gross Profit
$6.0M
-36.4%%
Operating Income
$608.2K
-83.3%%
Net Income
$1.2M
-67.6%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio
-312.8%
Poor

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
0/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating JIN MEDICAL INTERNATIONAL LTD.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
45
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
44
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 87% Coverage
Trade-Off Triangle Visualization A ternary plot showing ZJYL's balance between Growth (26.3%), Profitability (36.4%), and Safety (37.3%). Growth 26% Safety 37% Profitability 36%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

38th percentile vs peers
38
Key Signals
EPS Growth YoY 18.5% 61p Revenue CAGR 3Y 2.5% 43p Rev Growth YoY -12.0% 18p
Strengths
  • Superior capital returns - 2 return metrics above peer median
  • Net Debt/Ebitda in top 20% of peers (11.94, 94th percentile)
  • Conservative leverage compared to industry peers
Risks
  • Rev Growth Yoy in bottom 20% of peers (-12.0%)
  • Growth below peer median (percentile: 38)

Profitability

52th percentile vs peers
53
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

54th percentile vs peers
54
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for JIN MEDICAL INTERNATIONAL LTD..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$0.25
- - -
+108.3% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info